IVF
INVO Fertility, Inc.NASDAQHealthcare$2.06-0.96%ClosedMarket Cap: $2.9M
As of 2026-04-09
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.50
P/S
0.41
EV/EBITDA
-0.28
DCF Value
$-10,482.34
FCF Yield
-270.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
39.2%
Operating Margin
-370.2%
Net Margin
-417.0%
ROE
-471.5%
ROA
-153.8%
ROIC
-235.8%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $1.8M | $-2.6M | $-1.87 |
| Q2 2025 | $1.9M | $-5.3M | $-22.88 |
| Q1 2025 | $1.6M | $-17.4M | $-91.13 |
| Q4 2024 | $1.7M | $-3.6M | $-65.75 |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$20.00
Target (Median)
$20.00
Target Range
$20.00 - $20.00
1 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell
Trading Activity
Insider Trades
View AllKrigsvold Terah Reneeofficer: Chief Financial Officer
SellTue Jan 13
Krigsvold Terah Reneeofficer: Chief Financial Officer
SellTue Jan 13
Krigsvold Terah Reneeofficer: Chief Financial Officer
SellTue Jan 13
Krigsvold Terah Reneeofficer: Chief Financial Officer
SellTue Jan 13
Krigsvold Terah Reneeofficer: Chief Financial Officer
SellTue Jan 13
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
2.65
INVO Fertility, Inc. operates as a revenue-generating fertility business. It also focuses on the development of class clinical-stage assets in oncology and autoimmune diseases. The company was founded on January 5, 2007 and is headquartered in Sarasota, FL.